Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2013


Training ADME PK DM | Evaluation of ADMET Drug Properties in Drug Discovery and Development

22 Jan 2013 - 23 Jan 2013 - Sheraton Hotel Brussels Belgium



Bookmark and Share


Mondial Research has joined with strategic partners from the Biotech and Pharmaceutical Industry to bring together scientific experts to present and discuss recent advances towards accurately predicting human toxicities and screening earlier in the drug discovery process.


Agenda Topics
ADME Optimisation for Drug Design/Discovery
PK/PD
High Content Screening
Biobased Cellular Toxicity Assays
Metabolomics
MIP-DILI | IMI
IPS-derived Primary Cultures for Toxicity Assays
In Vitro QT Prolongation Assays with Cardiomyocytes
Genotoxicity
Biomarker Identification with Toxicogenomics
New Therapeutic Targets in Drug Design/Discovery
Pharmacogenomics and Drug Safety
Regulatory Issues in ADME
A Novel Human Hepatocyte Assay for Accurate Prediction of Severe DILI Drugs
Translational Investigation of Drug Disposition in Children
and much more...

Early Booking - £999 GBP for Conference Only if you book before October 31, 2012

Please contact cristinah@mondialresearchgroup.com for more info. You can also register online at the link above.



Further information
Scientific News
Inspiring Futuristic Innovation: Brain ‘Organoids’
Scientists create artificial brains, providing an advanced model for studying brain tumour development.
Parkinson's Disease Linked to Microbiome
Scientists have discovered a link between intestinal bacteria and Parkinson's disease.
Making Personalized Medicine a Reality
Groundbreaking technique developed at McMaster University is helping to pave the way for advances in personalized medicine.
Top 10 Life Science Innovations of 2016
2016 has seen the release of some truly innovative products. To help you digest these developments, The Scientist have listed their top picks for the year.
Possible Treatment for Rare Vascular Disease
Researchers manage to reverse hereditary haemorrhagic telangiectasia in mice, if successful in humans it could lead to improved treatment for the disease.
Cracking the Code of a Deadly Virus
Researchers have exploited weaknesses in VEEV's genetic code, creating a far less deadly variant.
New Compound to Reduce Tumor Growth
Researchers at Stanford found that a new cell surface receptor they created is effective at inhibiting cancer growth in mice.
Vaccination Against UTIs
Researchers have successfully vaccinated mice against E.coli growth in the bladder and kidneys.
Toxoplasma’s Balancing Act Explained
Parasite’s method of rewiring our immune response leads to novel tool for drug tests.
Common Virus Helps Fight Liver Cancer
Reovirus, a cause of childhood colds, stimulates the immune system to kill cancerous cells.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!